Aid as a Weapon: Shaping Global Health for Geopolitical Ends
THE ACTORS: Who is involved in this story? The Trump Administration (2017-2021, and potential 2025+): Characterized by an 'America First' policy, often prioritizing bilateral deals and de-emphasizing multinational aid, or linking aid to specific political concessions. USAID: The U.S. Agency for International Development, the primary implementer of US foreign aid, including HIV/AIDS programs like
PEPFAR (President's Emergency Plan for AIDS Relief). Uganda: A recipient nation, historically strategically important in East Africa, and heavily reliant on foreign aid for health initiatives, particularly HIV/AIDS prevention and treatment. Its government, led by President Yoweri Museveni since 1986, has a complex relationship with Western donors, often balancing aid dependency with sovereign
interests. Pharmaceutical Companies: Often beneficiaries of aid programs, as they manufacture the drugs and supplies purchased through initiatives like PEPFAR. THE FUNDING: Where does their money come from? US Taxpayers: The ultimate source of USAID and PEPFAR funding. PEPFAR Budget: Under the Trump administration, there were significant proposed cuts to foreign aid budgets, though Congress often
restored much of the PEPFAR funding due to its bipartisan support. However, the threat of cuts and redirection of funds created instability and strategic shifts. For instance, the 2018 budget proposal sought to dramatically reduce foreign assistance by 32% overall (Council on Foreign Relations, 2017), including potential impacts on global health. Ugandan Government: Contributes to its own health